Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bassem I Yamout

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
International Journal of Stroke : Official Journal of the International Stroke Society|September 15, 2012
Demographics, socio-economic characteristics, and risk factor prevalence in patients with non-cardioembolic ischaemic stroke in low- and middle-income countries: the OPTIC registryHalim Abboud, Julien Labreuche, Antonio Arauz, et al.
Multiple Sclerosis and Related Disorders|June 17, 2019
Risk of relapses during pregnancy among multiple sclerosis patientsRaed Alroughani, Saeed Akhtar, Maya Zeineddine, et al.
Neurosciences (Riyadh, Saudi Arabia)|March 24, 2011
The importance of quality-of-life assessment in the management of patients with multiple sclerosis. Recommendations from the Middle East MS Advisory GroupAbdelrahman M Al-Tahan, Mohammed A Al-Jumah, Saeed M Bohlega, et al.
Stroke|March 12, 2019
Impact of Low Ankle-Brachial Index on the Risk of Recurrent Vascular EventsHalim Abboud, Linsay Monteiro Tavares, Julien Labreuche, et al.
Journal of the Neurological Sciences|January 3, 2016
JC virus seroprevalence and seroconversion in multiple sclerosis cohort: A Middle-Eastern studyRaed Alroughani, Saeed Akhtar, Samar F Ahmed, et al.
The International Journal of Neuroscience|April 9, 2010
Adherence to disease-modifying drugs in patients with multiple sclerosis: a consensus statement from the Middle East MS Advisory GroupBassem I Yamout, Maurice Dahdaleh, Mohammed Ali Al Jumah, et al.
Multiple Sclerosis International|January 24, 2014
Future of management of multiple sclerosis in the middle East: a consensus view from specialists in ten countriesMohammed Aljumah, Raed Alroughani, I Alsharoqi, et al.
Multiple Sclerosis and Related Disorders|May 27, 2015
Functional clinical outcomes in multiple sclerosis: Current status and future prospectsRana Karabudak, Maurice Dahdaleh, Mohammed Aljumah, et al.
BMC Neurology|February 14, 2014
Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoringRaed A Alroughani, Hany M Aref, Saeed A Bohlega, et al.
Multiple Sclerosis International|January 13, 2017
Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus RisksRaed Alroughani, Ayse Altintas, Mohammed Al Jumah, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
International Journal of Stroke : Official Journal of the International Stroke Society|September 15, 2012
Demographics, socio-economic characteristics, and risk factor prevalence in patients with non-cardioembolic ischaemic stroke in low- and middle-income countries: the OPTIC registryHalim Abboud, Julien Labreuche, Antonio Arauz, et al.
Multiple Sclerosis and Related Disorders|June 17, 2019
Risk of relapses during pregnancy among multiple sclerosis patientsRaed Alroughani, Saeed Akhtar, Maya Zeineddine, et al.
Neurosciences (Riyadh, Saudi Arabia)|March 24, 2011
The importance of quality-of-life assessment in the management of patients with multiple sclerosis. Recommendations from the Middle East MS Advisory GroupAbdelrahman M Al-Tahan, Mohammed A Al-Jumah, Saeed M Bohlega, et al.
Stroke|March 12, 2019
Impact of Low Ankle-Brachial Index on the Risk of Recurrent Vascular EventsHalim Abboud, Linsay Monteiro Tavares, Julien Labreuche, et al.
Journal of the Neurological Sciences|January 3, 2016
JC virus seroprevalence and seroconversion in multiple sclerosis cohort: A Middle-Eastern studyRaed Alroughani, Saeed Akhtar, Samar F Ahmed, et al.
The International Journal of Neuroscience|April 9, 2010
Adherence to disease-modifying drugs in patients with multiple sclerosis: a consensus statement from the Middle East MS Advisory GroupBassem I Yamout, Maurice Dahdaleh, Mohammed Ali Al Jumah, et al.
Multiple Sclerosis International|January 24, 2014
Future of management of multiple sclerosis in the middle East: a consensus view from specialists in ten countriesMohammed Aljumah, Raed Alroughani, I Alsharoqi, et al.
Multiple Sclerosis and Related Disorders|May 27, 2015
Functional clinical outcomes in multiple sclerosis: Current status and future prospectsRana Karabudak, Maurice Dahdaleh, Mohammed Aljumah, et al.
BMC Neurology|February 14, 2014
Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoringRaed A Alroughani, Hany M Aref, Saeed A Bohlega, et al.
Multiple Sclerosis International|January 13, 2017
Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus RisksRaed Alroughani, Ayse Altintas, Mohammed Al Jumah, et al.
Pageof 4